T3	Subject 3 26	three of these patients
T4	Treatment 142 196	300 mg of cytarabine daily for the preceding five days
T5	Effect 84 107	cutaneous herpes zoster
T7	Population 3 8	three
T8	Dosage 142 148	300 mg
T9	Drug 152 162	cytarabine
T10	Freq 163 168	daily
T11	Duration 177 196	preceding five days
T6	Adverse_event 108 117	developed
E1	Adverse_event:T6